University of California, San Francisco
San Francisco, California, 94143, United States
NCT Number: NCT01752478
The purpose of this study to is to determine the incidence of post-operative ptosis in patients undergoing vitreoretinal surgery. An additional purpose is to identify pre-operative and intra-operative factors which correlate to the development of post-operative ptosis in vitreoretinal surgery cases.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
San Francisco, California, 94143, United States
This study will evaluate patients who will undergo vitreoretinal surgery at UCSF Medical Center and San Francisco General Hospital. After informed consent has been obtained, the measurement of eyelid parameters such as levator function, palpebral fissure height, upper eyelid crease height, MRD1 and MRD2 will be collected at pre-operative and post-operative follow up visits. External eye photographs taken at each visit will be evaluated by a masked reader who will calculate the eyelid parameters. Dermographic data and intraoperative factors such as operative time and type of procedure will be collected. For statistical analysis, Repeated ANOVA, Paired t-test, Wilcoxon signed rank test, Chi-square test and Pearson's correlation analysis will be calculated with SPSS software.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline to 6 months
Difference between levator function at baseline and 6 months after surgery
Time frame: At operation
Record of operative surgical time in each type of operation
Time frame: Baseline to 6 months
Difference in palpebral fissure height, MRD1 and MRD2 between baseline and each post-operative visit.
Time frame: baseline to 6 months
Incidence of clinically significant ptosis, defined as upper eyelid drooping of more than 2 mm.
University of California, San Francisco
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04235803
Blepharoptosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
San Francisco, California, United States
View Trial DetailsNCT05945615
Blepharoptosis, Dyskinesias
Hershey, Pennsylvania, United States
View Trial DetailsNCT05890027
Blepharoptosis, Eye Diseases
Miami, Florida, United States
View Trial DetailsNCT03818204
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Boston, Massachusetts, United States
View Trial Details